Kirr Marbach & Co’s Quipt Home Medical QIPT Stock Holding History

Kirr Marbach & Co’s Portfolio QIPT Stock Details QIPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-28,500	Closed	-$160K	–	57
2021 Q4	$160K	Hold	28,500	–	–	0.04%	55
2021 Q3	$180K	Hold	28,500	–	–	0.05%	55
2021 Q2	$179K	Buy	+28,500	New	+$175K	0.05%	54

Other funds holding QIPT

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

AWCI

Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Kirr Marbach & Co's QIPT Position: Q1 2022 in Review

Kirr Marbach & Co sold out of Quipt Home Medical (QIPT) in Q1 2022, closing a stake of 28,500 shares — an estimated $160K sold.

Kirr Marbach & Co first reported a position in QIPT in Q2 2021 and held it in 3 quarters. The position peaked at $180K in Q3 2021. 32 funds tracked by Wall St. Rank hold QIPT as of Q1 2022.

Kirr Marbach & Co reported no remaining Quipt Home Medical position as of Q1 2022 after selling out during the quarter.
Kirr Marbach & Co sold 28,500 Quipt Home Medical shares in Q1 2022, an estimated $160K.
Kirr Marbach & Co first reported a position in Quipt Home Medical in Q2 2021 and held it in 3 quarters.
Kirr Marbach & Co's Quipt Home Medical position peaked at $180K in Q3 2021.
32 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2022.

Based on Kirr Marbach & Co's 13F filing for Q1 2022, filed 3 May 2022.